Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1896832

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1896832

Oncology Nutrition Market Size, Share, and Growth Analysis, By Cancer Type, By Nutrition Type, By Formulation, By Distribution Channel, By End-User, By Region - Industry Forecast 2026-2033

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Oncology Nutrition Market size was valued at USD 2.42 Billion in 2024 and is poised to grow from USD 2.63 Billion in 2025 to USD 5.21 Billion by 2033, growing at a CAGR of 8.9% during the forecast period (2026-2033).

The oncology nutrition market is experiencing robust expansion, fueled by the rising incidence of cancer and an increasing understanding of the critical role nutrition plays in cancer treatment. This growth is largely attributed to the surge in cancer patients undergoing therapies like chemotherapy and radiation, which can lead to significant nutritional deficiencies. Specialized diets and nutritional interventions are essential for managing symptoms, preserving weight, and enhancing treatment outcomes for these patients. Additionally, heightened awareness regarding nutrition's potential to mitigate cancer risks and promote overall health is bolstering market demand. Key industry players are actively investing in research and development to launch innovative products and services tailored to meet the unique nutritional requirements of cancer patients.

Top-down and bottom-up approaches were used to estimate and validate the size of the Oncology Nutrition market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Oncology Nutrition Market Segments Analysis

Global Oncology Nutrition Market is segmented by cancer type, nutrition type, formulation, distribution channel, end-user and region. Based on cancer type, the market is segmented into gastrointestinal cancer, lung cancer, breast cancer, blood cancer, liver cancer and others. Based on nutrition type, the market is segmented into enteral nutrition and parenteral nutrition. Based on formulation, the market is segmented into powder, liquid and tablet. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Based on end-user, the market is segmented into hospitals, homecare settings and specialty clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Oncology Nutrition Market

A significant factor propelling the oncology nutrition market is the rising incidence of cancer globally. As cancer affects a large number of individuals, many patients face nutritional challenges and unintended weight loss, stemming both from the illness and the adverse effects of treatments like chemotherapy and radiation. Oncology nutrition solutions are essential in delivering necessary nutrients, alleviating treatment side effects, and enhancing the general health and quality of life for those undergoing cancer therapy. Additionally, there is an increasing acknowledgment of the critical role that supportive care, particularly nutritional therapy, plays in the overall management of cancer, which further stimulates the demand for these specialized products and services.

Restraints in the Oncology Nutrition Market

A major constraint in the oncology nutrition market is the elevated pricing of specialized nutrition products tailored for cancer patients. These products are meticulously formulated to meet the distinct nutritional requirements of individuals undergoing cancer treatment, resulting in increased costs associated with research and development, production, and stringent quality control measures. Furthermore, the necessity for individualized nutrition plans and personalized counseling services exacerbates the expense, making these products less accessible. This financial barrier can hinder affordability, particularly impacting patients in lower-income areas, which may limit their ability to obtain essential nutrition support during treatment.

Market Trends of the Oncology Nutrition Market

The Oncology Nutrition market is increasingly witnessing a shift towards personalized nutrition interventions tailored to the specific needs of cancer patients. This trend highlights the critical role of nutrition in enhancing recovery and managing cancer symptoms. By leveraging advanced diagnostic techniques, such as genetic profiling and biomarker analysis, healthcare professionals can identify unique nutritional deficiencies and requirements relative to individual cancer types and treatment plans. Personalized nutrition strategies aim to optimize dietary intake, bolster immune function, alleviate treatment-related side effects, and ultimately improve the overall quality of life for patients. This movement towards precision and individualized nutrition signifies a broader embrace of holistic care within oncology.

Product Code: SQMIG35D2089

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Case Studies

Global Oncology Nutrition Market Size by Cancer Type & CAGR (2026-2033)

  • Market Overview
  • Gastrointestinal Cancer
  • Lung Cancer
  • Breast Cancer
  • Blood Cancer
  • Liver Cancer
  • Others

Global Oncology Nutrition Market Size by Nutrition Type & CAGR (2026-2033)

  • Market Overview
  • Enteral Nutrition
    • Standard Formulas
    • Disease-Specific Formulas
  • Parenteral Nutrition
    • Total Parenteral Nutrition (TPN)
    • Peripheral Parenteral Nutrition (PPN)

Global Oncology Nutrition Market Size by Formulation & CAGR (2026-2033)

  • Market Overview
  • Powder
  • Liquid
  • Tablet

Global Oncology Nutrition Market Size by Distribution Channel & CAGR (2026-2033)

  • Market Overview
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Oncology Nutrition Market Size by End-User & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Homecare Settings
  • Specialty Clinics

Global Oncology Nutrition Market Size & CAGR (2026-2033)

  • North America (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
    • US
    • Canada
  • Europe (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Nestle Health Science (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danone S.A. (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius Kabi AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mead Johnson Nutrition Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hormel Foods Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Meiji Holdings Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Victus, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Global Health Products, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nutritional Medicinals, LLC (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kate Farms (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ajinomoto Co., Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Nutrition (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danone Nutricia (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius SE & Co. KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nutritional Resources Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!